Literature DB >> 31845140

Composite Length of Stay, An Outcome Measure of Postoperative and Readmission Length of Stays in Pancreatoduodenectomy.

Gregory A Williams1, Jingxia Liu2, William C Chapman3, William G Hawkins1, Ryan C Fields4, Dominic E Sanford1, Majella B Doyle3, Chet W Hammill1, Adeel S Khan3, Steven M Strasberg5.   

Abstract

PURPOSE: Postoperative length of stay (PLOS) and readmission rate are pancreatoduodenectomy (PD) outcome measures, which are reported individually but may be interrelated. The purpose of this study was to evaluate how well a composite length of stay measure (CLOS) that included PLOS and readmission length of stay describes outcomes. To do so, we evaluated how well CLOS correlated to postoperative complications absolutely and compared to PLOS.
METHODS: A total of 668 PDs performed between 2011 and 2018 were evaluated. CLOS was calculated from PLOS and readmission length of stay. Complication severity was judged by the Modified Accordion Grading System (MAGS). Multinomial logistical regression models (MLRM) were used to investigate the relationship between either PLOS or CLOS and complications. Multilevel and pairwise area under curves (AUC) using SAS macro %MultAUC were provided for both models.
RESULTS: A total of 432 of 668 patients (65%) developed complications. One hundred seventy-seven patients (27%) were readmitted. Mean PLOS was 10.2 days (7.1 SD) and mean CLOS was 12.3 days (10.1 SD). PLOS and CLOS both were correlated linearly to MAGS grade. Spearman correlation coefficient for CLOS vs. MAGS of 0.68 was higher than that of 0.49 for PLOS vs. MAGS. Multilevel AUC from MLRM using PLOS was 0.66, but multilevel AUC from MLRM using CLOS was 0.71. DISCUSSION: CLOS provides an accurate estimate of hospital day utilization per patient for PD, reflecting not only the basal hospital recovery time for PD but the added time needed because of readmissions due to complications. It is tightly correlated to number and severity of postoperative complications.

Entities:  

Keywords:  Composite length of stay; Length of stay; MAGS; Modified Accordion Grading System; Pancreatoduodenectomy; Postopertaive complications; Postopertaive length of stay; Readmission length of stay; Readmission rate; Whipple procedure

Mesh:

Year:  2019        PMID: 31845140      PMCID: PMC7295670          DOI: 10.1007/s11605-019-04475-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

1.  Hospital readmission after pancreaticoduodenectomy.

Authors:  Dawn M Emick; Taylor S Riall; John L Cameron; Jordan M Winter; Keith D Lillemoe; Joann Coleman; Patricia K Sauter; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

2.  Proposed classification of complications of surgery with examples of utility in cholecystectomy.

Authors:  P A Clavien; J R Sanabria; S M Strasberg
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

3.  Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program.

Authors:  Matthew R Porembka; Bruce Lee Hall; Mitzi Hirbe; Steven M Strasberg
Journal:  J Am Coll Surg       Date:  2010-03       Impact factor: 6.113

Review 4.  Minimally invasive pancreatoduodenectomy.

Authors:  Michael L Kendrick; Jony van Hilst; Ugo Boggi; Thijs de Rooij; R Matthew Walsh; Herbert J Zeh; Steven J Hughes; Yoshiharu Nakamura; Charles M Vollmer; David A Kooby; Horacio J Asbun
Journal:  HPB (Oxford)       Date:  2017-03       Impact factor: 3.647

5.  Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?

Authors:  Zachary J Kastenberg; John M Morton; Brendan C Visser; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2012-09-24       Impact factor: 3.647

6.  Readmission after major pancreatic resection: a necessary evil?

Authors:  Tara S Kent; Teviah E Sachs; Mark P Callery; Charles M Vollmer
Journal:  J Am Coll Surg       Date:  2011-08-16       Impact factor: 6.113

7.  Early versus late hospital readmission after pancreaticoduodenectomy.

Authors:  Eric B Schneider; Joseph K Canner; Faiz Gani; Yuhree Kim; Aslam Ejaz; Gaya Spolverato; Timothy M Pawlik
Journal:  J Surg Res       Date:  2015-02-21       Impact factor: 2.192

8.  Index versus Non-index Readmission After Hepato-Pancreato-Biliary Surgery: Where Do Patients Go to Be Readmitted?

Authors:  Eliza W Beal; Fabio Bagante; Anghela Paredes; Qinyu Chen; Ozgur Akgul; Katiuscha Merath; Mary E Dillhoff; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

9.  Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States.

Authors:  Omar Hyder; Rebecca M Dodson; Hari Nathan; Eric B Schneider; Matthew J Weiss; John L Cameron; Michael A Choti; Martin A Makary; Kenzo Hirose; Christopher L Wolfgang; Joseph M Herman; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2013-12       Impact factor: 14.766

10.  Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients.

Authors:  Syed A Ahmad; Michael J Edwards; Jeffrey M Sutton; Sanjeet S Grewal; Dennis J Hanseman; Shishir K Maithel; Sameer H Patel; David J Bentram; Sharon M Weber; Clifford S Cho; Emily R Winslow; Charles R Scoggins; Robert C Martin; Hong Jin Kim; Justin J Baker; Nipun B Merchant; Alexander A Parikh; David A Kooby
Journal:  Ann Surg       Date:  2012-09       Impact factor: 12.969

View more
  4 in total

1.  Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment.

Authors:  Lukas Andreas Heger; Nils Elsen; Marina Rieder; Nadine Gauchel; Urte Sommerwerck; Christoph Bode; Daniel Duerschmied; Mark Oette; Ingo Ahrens
Journal:  BMC Infect Dis       Date:  2022-05-23       Impact factor: 3.667

2.  Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched Study.

Authors:  Yongjia Yan; Annie Yang; Li Lu; Zhicheng Zhao; Chuan Li; Weidong Li; Joseph Chao; Tong Liu; Yuman Fong; Weihua Fu; Yanghee Woo
Journal:  Ann Surg Oncol       Date:  2020-08-29       Impact factor: 5.344

3.  Improved outcomes with minimally invasive pancreaticoduodenectomy in patients with dilated pancreatic ducts: a prospective study.

Authors:  Heidy Cos; Michael T LeCompte; Sanket Srinivasa; Jorge Zarate Rodriguez; Cheryl A Woolsey; Gregory Williams; Siddarth Patel; Adeel Khan; Ryan C Fields; Maria B Majella Doyle; William C Chapman; Steven M Strasberg; William G Hawkins; Chet W Hammill; Dominic E Sanford
Journal:  Surg Endosc       Date:  2021-07-07       Impact factor: 3.453

4.  Enhanced recovery pathway after open pancreaticoduodenectomy reduces postoperative length of hospital stay without reducing composite length of stay.

Authors:  Rony Takchi; Heidy Cos; Gregory A Williams; Cheryl Woolsey; Chet W Hammill; Ryan C Fields; Steven M Strasberg; William G Hawkins; Dominic E Sanford
Journal:  HPB (Oxford)       Date:  2021-06-16       Impact factor: 3.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.